Ticker Symbol: INM

InMed Pharmaceuticals Inc

$1.40 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Canada Currency: USD Asset Type: Common Stock CIK:0001728328

Company Profile

inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology (except Nanobiotechnology)

Standard Industrial Classification Code (SIC code): 8731

Address: Suite 310, 815 W. Hastings Street

Website: https://www.inmedpharma.com/

CEO: Eric Adams

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $0.71

Change: $0.03 ( 5.63%)

Days Range: $0.65 - $0.73

Beta: 0.77

52wk. High: $4.76

52wk. Low: $0.45

Ytd. Change -60.95%

50 Day Moving Average: $0.74

200 Day Moving Average: $1.02

Shares Outstanding: 3328191

Valuation

Market Cap: 237.3M

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A